Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Klin Lab Diagn ; 65(8): 516-520, 2020 Jul 20.
Artigo em Russo | MEDLINE | ID: mdl-32762196

RESUMO

Moxifloxacin and imunofan peptide concentrations - dependent Clostridium difficile growth rate was analyzed in vitro. In the course of our study, it was revealed imunofan peptide at concentrations 0.05, 0.25 µg/ml has antimicrobial characteristics against toxigenic C. difficile strain. At the same time, with the peptide and the antibiotic combined interaction, we observed moxifloxacin concentration 0-1.5 MIC stimulates C. difficile growth, regardless of the imunofan concentration. Concentrations of maximum growth inhibition for C. difficile were also established with the combined effects peptide imunofan and antibiotic moxifloxacin - 1.5 µg/ml and 2.5 MIC, respectively.


Assuntos
Antibacterianos , Clostridioides difficile , Infecções por Clostridium , Moxifloxacina , Oligopeptídeos , Antibacterianos/farmacologia , Clostridioides difficile/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Moxifloxacina/farmacologia , Oligopeptídeos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA